Search
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 650 items.
Counterfeit COVID-19 antigen rapid test kits found in Ontario
Health Canada is warning consumers about counterfeit BTNX Rapid Response COVID-19 antigen rapid test kits (25-pack boxes) found in Ontario. The counterfeit devices were sold online by a distributor named Healthful Plus, without the required licence to…
AlertPublic advisory | 2022-08-05
Unauthorized health products seized from Productos Latinos El Aguila in Leamington, Ontario
Health Canada seized numerous unauthorized health products from Productos Latinos El Aguila located at 42 Erie St S, Leamington, Ontario. The seized products include seven that are labelled to contain prescription drugs and may pose serious health risks…
AlertPublic advisory | 2022-08-05
IMVAMUNE Vaccine: Updated Storage Conditions and Shelf Life
On July 27, 2022, Bavarian Nordic submitted data to Health Canada characterizing shelf life for alternative storage conditions for IMVAMUNE. The IMVAMUNE Vaccine Product Monograph indicates: “Store frozen at -20°C ± 5°C or -50°C ± 10°C or -80°C ± 10°C.…
AlertHealth professional risk communication | 2022-07-29
Equate (lemon flavour), Personnelle (lemon flavour) and Life Brand (lemon and cherry flavours) Magnesium citrate oral solution saline laxatives recalled due to potential microbial contamination
Health Canada is advising that all lots of Equate (lemon flavour), Life Brand (lemon and cherry flavours) and Personnelle (lemon flavour) Magnesium citrate oral solution saline laxative (NPN 80015316) are being recalled by the importer, Shandex Sales…
AlertPublic advisory | 2022-07-24
Health Canada warns about certain hand sanitizers that may pose health risks (Part 2 – March 31, 2021 to present)
Certain lots of hand sanitizers do not meet Health Canada requirements. Issues include:
containing (or possibly containing) ingredients that are not permitted by Health Canada;
containing undeclared impurities at elevated levels;
improper…
AlertPublic advisory | 2022-07-11
Unauthorized health products seized from three herbal medicine stores in Calgary, Alberta
UPDATE (June 15, 2022):
Health Canada is warning consumers about additional unauthorized products seized from three herbal medicine stores in Calgary, Alberta, after testing found they contain drugs that are not listed on the product label, which may…
AlertPublic advisory | 2022-06-16
Distribution of a New Presentation of SPIKEVAX (elasomeran) COVID-19 Vaccine (0.10 mg/mL in 2.5 mL multidose vial) with English-only Vial and Carton Labels
A new presentation of SPIKEVAX (elasomeran) with a concentration of 0.10 mg/mL in a 2.5 mL multidose vial was authorized on June 01, 2022. In order to provide rapid access to the new presentation of SPIKEVAX (0.10 mg/mL, 2.5 mL multidose vial), Moderna…
AlertHealth professional risk communication | 2022-06-06
Leucovorin Calcium Injection: Out of Specification
The assay is out of specification in the affected lot(s).
RecallHealth product recall | 2022-05-13
Advanced Relief Eye Drops: product safety
The complaint bottle contains Naphazolin HCl 0.013% and Glycern 0.26%.
RecallHealth product recall | 2022-05-09
One lot of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops recalled because of a packaging error that may pose health risks
Teva Canada Ltd. is recalling one lot each of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops because of a packaging error. Some bottles may contain ingredients that are not listed on the label and that may pose health…
AlertPublic advisory | 2022-05-07
The Newfoundland Distillery Company - Fighting Spirit: Acetaldehyde outside acceptable limit
The affected lots may contain an acetaldehyde concentration that is outside the acceptable limit.
RecallHealth product recall | 2022-04-21
Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
UPDATED INFORMATION – May 6, 2022
Further to the communication below, issued on March 15, 2022, regarding the potential for the presence of particulate matter in vials of Sodium Acetate Injection, USP (DIN 02139529) from lot 6126554, Fresenius Kabi…
AlertHealth professional risk communication | 2022-03-15
Ranitidine products recalled because of a nitrosamine impurity
UPDATE: March 11, 2022 – Pharmascience Inc. recalls 30 lots of 150 mg over-the-counter ranitidine packaged in blister packs
Pharmascience Inc. is recalling 30 lots of over-the-counter ranitidine drugs (150 mg tablets), packaged in blister packs, after…
AlertInformation update | 2022-03-11
Anticipated shortage of euthanasia products for animals
UPDATED INFORMATION – March 10, 2022
Further to the Health Canada communication below, issued on June 15, 2021, while initial estimates of supply and demand forecasted that the global shortage could impact Canada’s supply in early 2022, careful…
AlertHealth professional risk communication | 2022-03-10
0.9% Sodium Chloride Injection, USP and Lactated Ringer’s Injection, USP - Potential Leak During Pressure Infusion
Intravenous bags of Baxter’s 0.9% Sodium Chloride Injection, USP 500 mL and Lactated Ringer’s Injection, USP 500 mL from certain lots have the potential to leak when administered under pressure infusion due to a weak seal formation.
Affected lots are…
AlertHealth professional risk communication | 2022-03-09